Skip to Content (press ENTER)
North America
Canada
Investor Type
United States
Latin America
Argentina
Brazil
Chile
Colombia
Mexico
Panama
Uruguay
Asia Pacific
Australia
China (中国)
Investor Type
Hong Kong (香港 – 中文)
Investor Type
Hong Kong - English
Investor Type
Japan (日本)
Investor Type
Korea
Investor Type
Singapore
Investor Type
Taiwan (台灣)
Investor Type
Europe
Austria
Belgium
Denmark
Finland
France
Germany
Ireland
Italy
 
Luxembourg
Netherlands
Norway
Portugal
Spain
Sweden
Investor Type
A view of blue leather chairs along the side of a marble conference room table with a skyline view in the background.

Akan Oton

Managing Director

Headshot of Akan Oton looking at the camera.

Akan Oton is a member of Barings’ Capital Solutions team and leads the team’s investment strategy in healthcare. Akan joined the firm in 2017 and has worked in the industry since 1998, bringing over 24 years of experience. At the firm, Akan has led the growth of the team’s investment capabilities in pharmaceutical royalties and non-dilutive healthcare finance. Prior to joining the firm, Akan worked at Sandoz (a division of Novartis), where he was an Executive Director and responsible for product acquisition, licensing and led M&A initiatives in generics and specialty brand segments. Prior to Sandoz, Akan worked at Catalent Pharma Solutions, where he was responsible for product partnering and technology licensing for the company’s venture group. He has also held marketing leadership roles at both Cardinal Health and Johnson & Johnson. Akan holds a B.S. in Mechanical Engineering from Columbia University, an M.S. in Mechanical Engineering from Massachusetts Institute of Technology, where he was a National Science Foundation Graduate Fellow, and an M.B.A. from The Wharton School at the University of Pennsylvania. He is also a Certified Licensing Professional and a board member of the NJ Chapter of the Licensing Executive Society.